CAS No.:79902-63-9
Name: Simvastatin
Details Introduction
TOXICITY DATA with REFERENCE:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LD50 | oral | > 5gm/kg (5000mg/kg) | GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" GASTROINTESTINAL: NAUSEA OR VOMITING |
Oyo Yakuri. Pharmacometrics. Vol. 39, Pg. 95, 1990. |
| mouse | LD50 | intraperitoneal | 798mg/kg (798mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) |
Oyo Yakuri. Pharmacometrics. Vol. 39, Pg. 95, 1990. |
| mouse | LD50 | oral | 3gm/kg (3000mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) GASTROINTESTINAL: OTHER CHANGES |
Oyo Yakuri. Pharmacometrics. Vol. 39, Pg. 95, 1990. |
| mouse | LD50 | subcutaneous | 1009mg/kg (1009mg/kg) | BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Oyo Yakuri. Pharmacometrics. Vol. 39, Pg. 95, 1990. |
| rat | LD50 | intraperitoneal | 705mg/kg (705mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) |
Oyo Yakuri. Pharmacometrics. Vol. 39, Pg. 95, 1990. |
| rat | LD50 | oral | 4438mg/kg (4438mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) GASTROINTESTINAL: OTHER CHANGES |
Oyo Yakuri. Pharmacometrics. Vol. 39, Pg. 95, 1990. |
| rat | LD50 | subcutaneous | 672mg/kg (672mg/kg) | BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Oyo Yakuri. Pharmacometrics. Vol. 39, Pg. 95, 1990. |
| women | LDLo | oral | 108mg/kg/77W- (108mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" |
Australian and New Zealand Journal of Medicine. Vol. 25, Pg. 745, 1995. |
| women | TDLo | oral | 2800ug/kg/7D- (2.8mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LIVER: LIVER FUNCTION TESTS IMPAIRED |
Medical Journal of Australia. Vol. 155, Pg. 61, 1991. |
Consensus Reports:
SAFETY PROFILE:
Safty information about Simvastatin (CAS NO.79902-63-9) is:
Hazard Codes:
Xi
Risk Statements: 36/37/38
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-36
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36:Wear suitable protective clothing.
RIDADR: 3077
RTECS: EK7798000
HazardClass: 9
PackingGroup: III
Standards and Recommendations:
Analytical Methods:
Related Searches
Related Suppliers
- Afine Chemicals Limited
- Simagchem Corporation
- taizhou creating bio-pharm co.,ltd.
- Dayang Chem (Hangzhou) Co.,Ltd.
- HANWAYS CHEMPHARM CO.,LIMITED
- Hangzhou Dingyan Chem Co., Ltd
- Josun International Limited
- Jai Radhe Sales
- LIDE PHARMACEUTICALS LIMITED
- Kono Chem Co.,Ltd
- Xiamen Hisunny Chemical Co.,Ltd
- Venkataramana International
- GENPHARMA (INTERNATIONAL) PVT LTD
- Welfull Group Co., Ltd.
- Bristol Laboratories Ltd
- ARGOS INTERNATIONAL
- Umedica Laboratories Ltd.
- AliaPharm GmbH
- HUGELAND CHEMICAL CO.,LIMITED
- Agvar Chemicals Inc
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione

